Special Announcement
|
Learn more and register today: https://conference.cmsa.org/ Download the virtual conference attendee brochure here. Pat Stricker, RN, MEd Former Senior Vice President TCS Healthcare Technologies Congratulations to CMSA! CMSA has been a driving force in the case management industry for 30 years and is more relevant now than ever! It all started so case managers working in varied, unconnected organizations and in different locations could share aspects of care management, standards of practice, patient outcomes, performance expectations, new ideas and innovations, and other topics relevant to everyone. Thirty years ago the sharing of ideas with a large group of people in different locations in a timely manner was a much more difficult process. Remember, there were no conference calls yet, so information had to be shared in written format by “snail mail” or magazine articles. And that made it much more of a one-way sharing of information. Local case management groups working in different organizations began to gather monthly to discuss issues and plan educational programs. Slowly these local groups became regional and state professional organizations, associations or societies, thanks to the hard work and unwavering commitment of volunteer leaders who worked tirelessly to make these groups successful. Visit https://www.naylornetwork.com/cmsapulse/articles/index-v3.asp?aid=621910&issueID=72359 to view the full article online. |
|
Member Announcements
|
CMSA's Standards of Practice for Case Management, 2016 revision, provides practice guidelines for the case management industry and its diverse stakeholders. The impetus for the 2016 revision of the Standards is the need to emphasize the professional nature of the practice and role of the case manager. The 2016 Standards of Practice contain information about case management including an updated definition, practice settings, roles and responsibilities, case management process, philosophy and guiding principles, as well as the standards and how they are demonstrated.
Visit http://solutions.cmsa.org/acton/media/10442/sop-2016 to view the full article online. |
|
Visit https://www.naylornetwork.com/cmsapulse/articles/index-v3.asp?aid=621911&issueID=72359 to view the full article online. |
Featured Article
|
CMSA is proud to partner with PRIME for a new resource for Atopic Dermatitis. This web based app provides essential information, and practical tips and resources to assess and treat patients with moderate to severe atopic dermatitis. We’ve made it easy to help providers and patients navigate the complexity of AD decision-making and treatment. This app is provided by PRIME Education. There is no fee to participate. This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals. Start exploring here today!
Visit https://ad.care/?utm_source=cmsa&utm_medium=eban&utm_campaign=71WB202 to view the full article online. |
Articles and Links
|
We have extensive technology, but our most powerful tool continues to be our human spirit and will to endure. As case managers, we will continue to experience and face new challenges that will allow us to demonstrate our professional commitment and passion to help our neighbors and the global community. Read the 2020 conference issue of CMSA Today, Case Management Careers, at the link below! Visit https://www.cmsa.org/cmsatoday/ to view the full article online. |
|
Government agencies and healthcare organizations are providing a myriad of resources regarding COVID-19, assisting healthcare providers, patients and the general public to manage unprecedented health and financial challenges. CMSA has compiled a list of resources on a new page on our website, where members can access important toolkits and websites to navigate care and well-being.
Please visit https://www.cmsa.org/coronavirus-resources/ and check back often for new additions as we receive word of them. Also, please share with your colleagues and communities. Thank you! Visit https://www.cmsa.org/coronavirus-resources/ to view the full article online. |
|
As part of President Trump’s longstanding commitment to lowering drug prices, on June 17 the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would start to remove barriers to the development of payment models based on value for innovative new therapies. Therapies are coming to market today that fight disease in an entirely new way, including at the genetic level. While the impact of these therapies can be transformative, their costs are unprecedented. New approaches to payment are needed to allow the market room to adapt to these types of curative treatments while ensuring that public programs like Medicaid remain sustainable. Several proposals will also enhance CMS’s efforts to combat the opioid epidemic and make sure that opioid outpatient drug coverage is appropriate, medically necessary, and avoids adverse medical events. “CMS’s rules for ensuring that Medicaid receives the lowest price available for prescription drugs have not been updated in thirty years and are blocking the opportunity for markets to create innovative payment models,” said CMS Administrator Seema Verma. “By modernizing our rules, we are creating opportunities for drug manufacturers to have skin in the game through payment arrangement that challenge them to put their money where their mouth is.” Source: Centers for Medicare and Medicaid Services
Visit https://www.cms.gov/newsroom/press-releases/cms-issues-proposed-rule-empower-commercial-plans-and-states-negotiate-payment-innovative-new to view the full article online. |